openPR Logo
Press release

PSMA Pet Imaging Market Expected to Reach $2.0 Billion by 2031: Market Research Projections | Novartis Pharmaceuticals Corporation, Lantheus company, RadioMedix, Clarity Pharmaceuticals, Blue Earth Diagnostics, Inc

01-17-2025 07:30 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

PSMA Pet Imaging Market

PSMA Pet Imaging Market

Global PSMA PET Imaging Market reached US$ 1.5 billion in 2022 and is expected to reach US$ 2.0 billion by 2030, growing with a CAGR of 3% during the forecast period 2024-2031.

PSMA Pet Imaging Market analysis, according to DataM Intelligence, offers more than just an overview, it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.

Get a Free Sample PDF copy of the report - https://datamintelligence.com/download-sample/psma-pet-imaging-market

The PSMA Pet Imaging market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

PSMA PET Imaging refers to a type of positron emission tomography (PET) imaging that uses a radiotracer targeting Prostate-Specific Membrane Antigen (PSMA), a protein commonly found on the surface of prostate cancer cells. This imaging technique is particularly valuable in detecting prostate cancer, assessing its spread, and monitoring treatment effectiveness. PSMA PET imaging allows for more precise localization of cancerous lesions compared to traditional imaging methods, providing higher sensitivity and specificity for detecting both primary and metastatic prostate cancer. It is increasingly used in clinical settings to guide treatment decisions and improve patient outcomes.

Forecast Growth Projected:

The Global PSMA Pet Imaging Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the PSMA Pet Imaging Market:

Novartis Pharmaceuticals Corporation, Lantheus company, RadioMedix, Clarity Pharmaceuticals, Blue Earth Diagnostics, Inc., Siemens Medical Solutions USA, Inc., Eckert & Ziegler, Telix Pharmaceuticals, Canon Medical Systems, USA, and Jubilant Draximage Radiopharmacies, Inc., among others.

Segment Covered in the PSMA Pet Imaging Market:

By Technology: Gallium-68 (Ga-68) PSMA PET Imaging, Fluorine-18 (F-18) PSMA PET Imaging

By End-User: Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Research and Academic Centers

Industry Development:

On May 30, 2023, Blue Earth Diagnostics announced that the U.S. FDA had approved a new positron emission tomography (PET) imaging agent for prostate cancer. Named Posluma, this agent is specifically designed for PET scans of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer. It is intended for individuals with metastatic prostate cancer who are either candidates for therapy or have a suspected recurrence indicated by elevated PSA levels.

Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=psma-pet-imaging-market

Regional Break out:

The global PSMA Pet Imaging Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of PSMA Pet Imaging manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of PSMA Pet Imaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/psma-pet-imaging-market

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of PSMA Pet Imaging market?

➠ Who are the global key manufacturers of the PSMA Pet Imaging Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the PSMA Pet Imaging market opportunities and threats faced by the vendors in the global PSMA Pet Imaging Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the PSMA Pet Imaging market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PSMA Pet Imaging Market Expected to Reach $2.0 Billion by 2031: Market Research Projections | Novartis Pharmaceuticals Corporation, Lantheus company, RadioMedix, Clarity Pharmaceuticals, Blue Earth Diagnostics, Inc here

News-ID: 3819540 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Japan Single-Use Bioprocessing Products Market: Thermo Fisher, Sartorius & Cytiva Share - 2024-2031
Japan Single-Use Bioprocessing Products Market: Thermo Fisher, Sartorius & Cytiv …
Market Size and Forecast: Japan Single-Use Bioprocessing Products Market is expected to reach growth at a Significant CAGR during the forecast period 2024-2031 The Japan Single-Use Bioprocessing Products Market Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of
United States Pharmaceutical Packaging Market to Grow at 9.5% CAGR, Driven by Regulatory Compliance, Smart Packaging Adoption, and Biologics Expansion | DataM Intelligence
United States Pharmaceutical Packaging Market to Grow at 9.5% CAGR, Driven by Re …
The global Pharmaceutical Packaging Market is growing at a CAGR of 9.5% during the forecast period 2024-2031, according to DataM Intelligence. United States: Recent Industry Developments ✅ In October 2025, Amcor PLC launched a new series of recyclable cold-chain packaging solutions for biologic drugs, enhancing sustainability in temperature-sensitive shipments. ✅ In October 2025, West Pharmaceutical Services introduced a novel smart vial system with integrated sensors for real-time temperature and tamper monitoring. ✅
United States Optical Imaging Market to Grow at 12.4% CAGR, Reaching USD 4.0 billion by 2031, Led by Canon, Carl Zeiss, and Abbott Laboratories | DataM Intelligence
United States Optical Imaging Market to Grow at 12.4% CAGR, Reaching USD 4.0 bil …
The global Optical Imaging Market reached USD 1.6 billion in 2022 and is projected to reach USD 4.0 billion by 2031, growing at a CAGR of 12.4% during the forecast period 2024-2031, according to DataM Intelligence. United States: Recent Industry Developments ✅ In October 2025, Canon U.S.A. received FDA clearance for its next-generation optical coherence tomography (OCT) system with AI-enhanced diagnostic capabilities for ophthalmology. ✅ In October 2025, Abbott Laboratories
United States Precious Metal Market to Grow at 5.2% CAGR, Led by Newmont Corporation, Barrick Gold, and Wheaton Precious Metals | DataM Intelligence
United States Precious Metal Market to Grow at 5.2% CAGR, Led by Newmont Corpora …
The global Precious Metal Market reached USD 209.4 billion in 2023 and is projected to reach USD 300.3 million by 2031, growing at a CAGR of 5.2% during the forecast period 2024-2031, according to DataM Intelligence. United States: Recent Industry Developments ✅ In October 2025, Newmont Corporation announced the expansion of its Nevada Gold Mines complex, increasing gold production capacity by 15% through advanced extraction technologies. ✅ In October 2025, The

All 5 Releases


More Releases for PSMA

PSMA-Targeted Radioligand Therapies Market Size, Clinical Trials, Product Pipeli …
PSMA-Targeted Radioligand Therapies Market Size is estimated to be $470 million in 2024 and is expected to grow at an average yearly rate of around 6% during the timeframe (2025-2032). What is PSMA-Targeted Radioligand Therapies and what are the growth drivers of PSMA-Targeted Radioligand Therapies Market? Prostate-Specific Membrane Antigen (PSMA)-targeted radioligand therapies are an advanced form of targeted cancer treatment designed specifically for prostate cancer. PSMA is a protein
PSMA Antibody Market is estimated to expand at USD 3.5 billion by 2034, driven b …
" The PSMA (Prostate-Specific Membrane Antigen) antibody market is poised for significant growth, with a current market value estimated at approximately $1.2 billion in 2024. By 2034, this market is projected to reach around $3.5 billion, reflecting a robust Compound Annual Growth Rate (CAGR) of approximately 11.4% during the forecast period of 2025-2034. " Exactitude Consultancy., Ltd. released a research report titled "PSMA Antibody Market". This report covers the global PSMA
Psma Pet Imaging Market: Expected Positive Growth Trends Through 2024-2031
The Psma Pet Imaging Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach. Get a Free Sample PDF - https://datamintelligence.com/download-sample/psma-pet-imaging-market What is the projected growth rate (CAGR) of the Global Psma Pet
PSMA PET Imaging Market Size, Trends, Share & Forecast 2023-2030 | Industry Outl …
PSMA PET Imaging Market: Significant Growth Driven by Rising Cancer Detection Rates The global PSMA PET imaging market is expected to witness significant growth in the coming years. This growth can be attributed to several factors, including: Increasing adoption of PSMA PET for prostate cancer detection: Prostate cancer is the fourth most commonly diagnosed cancer globally. PSMA PET offers a more precise and sensitive technique for detecting prostate cancer compared to
PSMA-PET Imaging Market : Long-Term Value & Growth Seen Ahead| GE Healthcare, En …
The Latest research study released by HTF MI "Global PSMA-PET Imaging Market with 120+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know-how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint, and status. Understanding the segments helps in identifying the importance of different factors that aid market growth. Some of the Major Companies covered in this Research are GE
177-LUTETIUM-PSMA-617 Market 2020 Analysis by Expert to 2030
177-LUTETIUM-PSMA-617- Emerging Drug Insight and Market Forecast – 2030 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of 177-LUTETIUM-PSMA-617 Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life